The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Allogene Therapeutics Inc shares valued at $103,501 were purchased by Parker Geoffrey M. on Oct 21 ’24. At $2.84 per share, Parker Geoffrey M. acquired 36,404 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Douglas Earl Martin purchased 28,310 shares, netting a total of over 78,844 in proceeds.
Before that, MESSEMER DEBORAH M. had sold 18,641 shares from its account. In a trade valued at $42,488, the Director traded Allogene Therapeutics Inc shares for $2.28 each. Upon closing the transaction, the insider’s holdings decreased to 18,641 shares, worth approximately $0.54 million.
Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in late May. As of January 05, 2024, JMP Securities has decreased its “Mkt outperform” rating to a “Mkt perform” for ALLO. Earlier on January 05, 2024, Guggenheim downgraded its rating. Their new recommendation was “a Neutral” for ALLO stock which previously was a “a Buy”.
Analyzing ALLO Stock Performance
During the last five days, there has been a surge of approximately 21.97%. Over the course of the year, Allogene Therapeutics Inc shares have jumped approximately 0.31%. Shares of the company reached a 52-week high of $5.78 on 03/08/24 and a 52-week low of $2.01 on 07/05/24. A 50-day SMA is recorded $2.71, while a 200-day SMA reached $3.18. Nevertheless, trading volume fell to 4.03 million shares from 2.6 million shares the previous day.
Support And Resistance Levels for Allogene Therapeutics Inc (ALLO)
According to the 24-hour chart, there is a support level at 3.04, which, if violated, would cause prices to drop to 2.87. In the upper region, resistance lies at 3.34. The next price resistance is at 3.47. RSI (Relative Strength Index) is 63.87 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.30, which suggests the price will decrease in the coming days. Percent R is at 8.24%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
